Claudio Jommi

Novara, 28100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and Consistency.

Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and Consistency.

Journal: Journal of market access & health policy

Published: February 17, 2026

More and earlier data from AIFA: do they impact on the regional policies? Results from an exploratory analysis.

More and earlier data from AIFA: do they impact on the regional policies? Results from an exploratory analysis.

Journal: Global & regional health technology assessment

Published: December 17, 2025

Closing the first wave of drug innovativeness in italy: final evidence from 2017 to 2025.

Closing the first wave of drug innovativeness in italy: final evidence from 2017 to 2025.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: November 13, 2025

Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027.

Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027.

Journal: Health economics review

Published: August 21, 2025

Title Not Found

Title Not Found

Journal: Global & regional health technology assessment

Published: July 16, 2025

Title Not Found

Title Not Found

Journal: Global & regional health technology assessment

Published: July 10, 2025

Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.

Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.

Journal: Journal of cancer policy

Published: May 22, 2025

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Journal: BMJ open

Published: May 16, 2025

Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?

Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?

Journal: Journal of market access & health policy

Published: May 11, 2025

Obesity in Italy: An Empirical Analysis of Healthcare Consumption, Quality of Life and Comorbidities.

Obesity in Italy: An Empirical Analysis of Healthcare Consumption, Quality of Life and Comorbidities.

Journal: Medicina (Kaunas, Lithuania)

Published: April 28, 2025

Paving the road for a successful EU HTA Reform implementation.

Paving the road for a successful EU HTA Reform implementation.

Journal: Global & regional health technology assessment

Published: February 19, 2025

Value Attribution for Combination Treatments: Two Potential Solutions for an Insoluble Problem.

Value Attribution for Combination Treatments: Two Potential Solutions for an Insoluble Problem.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 15, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026